• 제목/요약/키워드: immunohistochemical

검색결과 1,932건 처리시간 0.031초

원발성 폐암환자의 혈청 및 조직에서의 p53단백 표현 (The Significance of p53 Expression in Serum and Tissue from Patients with Lung Cancer)

  • 장중현;성순희
    • Tuberculosis and Respiratory Diseases
    • /
    • 제45권2호
    • /
    • pp.333-340
    • /
    • 1998
  • 연구배경: 폐암은 전세계적으로 암중에서도 높은 발생빈도를 보이는 질환이며 흡연, 공해와 환경오염 등으로 인해 점차 증가하고 있다. 폐암에서는 다양한 유전학적 변화가 나타나는데 그중에서도 특히 p53의 유전자 변이와 그에 따른 p53 본래의 종양억제력의 상실은 종양발생에 관련되는 것으로 밝혀져 있다. P53 변이의 확인은 면역조직염색, PCR 분석법과 ESISA 분석 등으로 조사할 수 있다. 방 법: P53의 혈청학적 측정은 69명의 폐암환자와 대조군으로 42명 비폐암 호흡기질환자에서 조사되었다. 혈청 p53 변이단백은 ELISA 방법으로 측정하였고 조직 면역화학염색은 p53의 단크론항체를 이용하였다. 결 과: 혈청학적 검사에서 비소세포 폐암의 p53 변이단백은 0.28ng/mL, 소세포폐암은 0.20ng/mL, 그리고 대조군은 0.34ng/mL로서 세군간의 유의한 차이는 관찰되지 않았다. 또한 폐암의 임상병기에 따른 p53의 농도에는 어떤 상관성도 발견할 수 없었다. 폐암조직에 대한 p53 면역화학염색상 50%의 양성율을 보였으나 혈청학적 검사와는 어떤 상관성을 볼 수 없었다. 결 론: 결론적으로 본 연구의 변이 p53단백에 대한 혈청학적 검사는 폐암에 대한 진단적 가치는 없는 것으로 생각된다. 또한 원발성 폐암의 p53 변이를 확인하기 위한 조직면역화학염색은 50%에서 양성을 확인하였다.

  • PDF

IMMUNOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDIES ON TWO GASTRIC ENZYMES IN NEONATE, YOUNG AND ADULT GOATS

  • Amasaki, H.;Gozawa, S.;Akuzawa, R.;Suzuki, K.;Daigo, M.;Andren, A.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제3권4호
    • /
    • pp.281-285
    • /
    • 1990
  • The present paper demonstrates the expressions and amounts of pepsinogen and prochymosin in neonate, young and adult goat's proper gastric glandular regions by the immunochemical and the immunohistochemical analyses with the anti-bovine pepsinogen serum and anti-bovine chymosin serum. Each bovine serum was demonstrated to have reactivities against corresponding goat's antigen by immunochemical analses and enzymatic activities. The anti-pepsinogen was higher in the new born animals than the maternal milk feeding one, suggesting that the maternal milk might control the pepsinogen production in the proper gastric glands. The patterns of prochymosin expression in the goats was similar to that in cattle.

Accumulation of Heavy Metals in the Antarctic Clam Laternula elliptica

  • Lee, Yong-Seok;Jeong, Kye-Heon
    • 한국환경보건학회:학술대회논문집
    • /
    • 한국환경보건학회 2004년도 International Conference Global Environmental Problems and their Health Consequences
    • /
    • pp.87-91
    • /
    • 2004
  • Immunohistochemical and ultrastructural experiments were conducted to find out heavy metal accumulation in some selected organs such as the kidney, the hepatopancreas, and the gills of the Antarctic Clam Laternula elliptica According to the immunohistochemical study the subject organs of the clam showed reactions indicating the presence of MT(metallothionein), a metal-binding protein involved in metal detoxifying process. Examination under the transmission electron microscope also revealed that other ligands(e.g. metal-rich granules in the kidney) may play a role in metal accumulating and detoxifying process in L. elliptica. In the artificial exposure of the clam to Cd, it showed immediate subcellular responses, suggesting that this species can be used as rapid and efficient bioindicators for Cd exposure in natural environment.

  • PDF

체강삼출액의 진단에 있어서 p53 단백의 유용성 (Diagnostic Value of p53 Expression in the Evaluation of Effusions)

  • 이지신;박창수
    • 대한세포병리학회지
    • /
    • 제7권2호
    • /
    • pp.138-143
    • /
    • 1996
  • The diagnostic accuracy of routine cytological preparations from effusions ranges from 60% to 70%. Immunohistochemical markers, especially tumor-associated antigens, have been successfully employed to increase diagnostic sensitivity in effusion cytology. However, more than two different antibodies in diagnosis of effusions are needed. In the view of prevalence of abnormalities of p53 gene in human malignancies we investigated the diagnostic usefulness of demonstration of p53 protein immunoreactivity in distinguishing benign changes versus malignant processes in effusions. p53 protein expression was studied immunohistochemically in 76 effusions(28 malignant and 48 benign) using anti-human p53 antibody p53 immunoreactivity was identified in 19 of 28(67.9%) malignant effusions. In contrast, no p53 immunoreactivity was observed in all benign effusions. A specificity of 100% and a sensitivity of 67.9% were observed. These results suggest that immunohistochemical detection of p53 protein seems to be helpful in distinguishing benign changes versus malignant processes in effusions, although its principal limitation is its relatively low sensitivity.

  • PDF

폐실질안의 신경초종 체험 1례 (A Case of Intrapulmonary Neurilemmoma)

  • 박종호;백희종
    • Journal of Chest Surgery
    • /
    • 제30권5호
    • /
    • pp.540-543
    • /
    • 1997
  • 이 보고서에서는 최근에 저자 등이 5-100단백질을 함유하고 있는 아주 드문 폐 실질안의 신경종양을 경험하 였기에 보고하고자 한다. 이 환자는 47세 남자로 평소 증상은 없었으나, 신체검사에서 우연히 발견된 좌측 폐문의 종피를 주소로 내원한 자이다 이 종괴의 정확한 진단 및 치료를 위하여 수술을 시행하였으며, 병리 조직학적 검사에서 원발성 폐실질내 신경초종으로 판명되었다. 특수염색검사에서 종양안의 5-100단백질의 존재를 확인할 수 있었다.

  • PDF

Intracranial Solitary Fibrous Tumor

  • Jang, Jun-Won;Kim, Chang-Hyun;Yoo, Chong-Woo;Moon, Jae-Gon
    • Journal of Korean Neurosurgical Society
    • /
    • 제39권1호
    • /
    • pp.64-67
    • /
    • 2006
  • Solitary fibrous tumor is a spindle cell neoplasm that can arise in any place of the body. Intracranial solitary fibrous tumors are rare. To our knowledge, only 57 cases with intracranial lesion have been reported. In Korea three cases have been reported. Our case was a 23-year-old woman who presented with morning headache. MRI showed a large intra-axial mass involving falx with typically isointense and heterogeneous strong enhancement on T1 weighted image in the right parieto-occipital region. Histologically the tumor showed spindle shaped cells within matrix with thick collagen deposition, hypercellularity, focal necrosis, and pleomorphism. Immunohistochemical study demonstrated diffuse positivity for CD34, Vimentin, Reticulin. In case of the intracranial tumors involving the meninges, we also should consider the solitary fibrous tumor with immunohistochemical staining for accurate diagnosis.

미요시근육병 환자에서 밝혀진 Dysferlin 유전자 돌연변이 (Identification of a Dysferlin Gene Mutation in One Patient Showing Clinical Manifestation of Miyoshi Myopathy)

  • 지명구;김남희;김대성;최영철
    • Annals of Clinical Neurophysiology
    • /
    • 제11권2호
    • /
    • pp.59-63
    • /
    • 2009
  • Miyoshi myopathy (MM) is caused by the mutations of dysferlin gene (DYSF), which impairs the function of dysferlin protein causing muscle membrane dysfunction. We report a patient showing the MM phenotype who has a sister with LGMD 2B phenotype, along with the results of the immunohistochemical and molecular analyses of the DYSF gene. Immunohistochemical analysis noted negative immunoreactivity against dysferlin. Direct DNA sequencing of whole exons of DYSF gene revealed heterozygous nonsense mutations (c.610C>T + c.2494C>T). To our knowledge, this is the first reported MM case with this very combination of heterozygous mutations.

  • PDF